A single amino acid substitution in the Borna disease virus glycoprotein enhances the infectivity titer of vesicular stomatitis virus pseudotyped virus by altering membrane fusion activity
Microbiology and Immunology · 2024
DOI: 10.1111/1348-0421.13172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology and Immunology, 2024. Verfasst von Yusa Akiba und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of RNA Viruses, Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Borna disease virus, Virus Internalization, Amino Acid Substitution, Viral Envelope Proteins. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Kaketsuken, Institute for Life and Medical Sciences, Kyoto University.
Abstract (Originalsprache)
Borna disease virus 1 (BoDV‐1) causes acute fatal encephalitis in mammals, including humans. Despite its importance, research on BoDV‐1 cell entry has been hindered by low infectious viral particle production in cells and the lack of cytopathic effects, which are typically useful for screening. To address these issues, we developed a method to efficiently produce vesicular stomatitis virus (VSV) pseudotyped with glycoprotein (G) of members of the genus Orthobornavirus , including BoDV‐1. We discovered that optimal G expression is required to obtain a high infectivity titer of the VSV pseudotyped virus. Remarkably, the infectivity of the VSV pseudotyped virus with G from the BoDV‐1 strain huP2br was significantly higher than that of the VSV pseudotyped virus with G from the He/80 strain. Mutational analysis demonstrated that the methionine at BoDV‐1–G residue 307 increases the infectivity titer of VSV pseudotyped with BoDV‐1–G (VSV–BoDV‐1–G). A cell‒cell fusion assay indicated that this residue plays a pivotal role in membrane fusion, thus suggesting that high membrane fusion activity and a broad pH range for membrane fusion are crucial for achieving a high infectivity titer of VSV–BoDV‐1–G. This finding may be extended to increase the infectivity titer of VSV pseudotyped virus with other orthobornavirus G. Our study also contributes to identifying functional domains of BoDV‐1–G and provides insight into G‐mediated cell entry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of RNA Viruses, Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
- Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
- Department of Molecular Virology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Förderung
- Japan Agency for Medical Research and Development
- Kaketsuken
- Institute for Life and Medical Sciences, Kyoto University
- Japan Society for the Promotion of Science
Zitieren
APA
Akiba, Y., Matsugo, H., Kanda, T., Sakai, M., Makino, A., & Tomonaga, K. (2024). A single amino acid substitution in the Borna disease virus glycoprotein enhances the infectivity titer of vesicular stomatitis virus pseudotyped virus by altering membrane fusion activity. Microbiology and Immunology. https://doi.org/10.1111/1348-0421.13172
Vancouver
Akiba Y, Matsugo H, Kanda T, Sakai M, Makino A, Tomonaga K. A single amino acid substitution in the Borna disease virus glycoprotein enhances the infectivity titer of vesicular stomatitis virus pseudotyped virus by altering membrane fusion activity. Microbiology and Immunology. 2024. doi:10.1111/1348-0421.13172
BibTeX
@article{Akiba2024,
author = {Akiba, Yusa and Matsugo, Hiromichi and Kanda, Takehiro and Sakai, Modoka and Makino, Akiko and Tomonaga, Keizo},
title = {A single amino acid substitution in the Borna disease virus glycoprotein enhances the infectivity titer of vesicular stomatitis virus pseudotyped virus by altering membrane fusion activity},
journal = {Microbiology and Immunology},
year = {2024},
doi = {10.1111/1348-0421.13172}
}
EUVIMED